J B Chemicals and Pharmaceuticals Ltd
JBCHEPHARM (NSE)

1,561.00

12,122.08
Proj. ROE (%)
20.21
Proj. P/E (x)
24.97
Proj EV / EBITDA (x)
17.02
Proj. P/BV (x)
4.26
Proj. Revenue ( Cr.)
2,921.07

Stock View

STRONG BUY
Share on
The average score for J B Chemicals and Pharmaceuticals Ltd stands at 6 against 6, three months back.

J. B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). It is involved in the provision of product development services. The Company offers varied products and dosage forms across therapeutic categories, which includes gastroenterology, hypertension, dermatology, nephrology, respiratory, virology, diabetes, wound care, anti-infectives, pharmacovigilance and nicotine replacement therapy (NRT). Its offers lozenges, which includes center-filled, soft-centered lozenges, center-filled, powder lozenges, herbal lozenges, and medicated lozenges. Its APIs products include Diclofenac Sodium, Diclofenac Diethylamine, Diclofenac Acid, Diclofenac Potassium, Nifedipine, Atenolol, Cilnidipine, and Ciprofloxacin HCl. The Company exports its products to over 40 countries across the world.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
1,597.89
100 DMA ()
1,611.45
200 DMA ()
1,660.49
52 Weeks Range
1,342.20
1,985.00
Street View :-
Bearish
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity